S Virág

402 total citations
25 papers, 312 citations indexed

About

S Virág is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S Virág has authored 25 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S Virág's work include Lipoproteins and Cardiovascular Health (7 papers), Cholesterol and Lipid Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). S Virág is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Cholesterol and Lipid Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). S Virág collaborates with scholars based in Hungary, Slovakia and United Kingdom. S Virág's co-authors include L Jakab, J Székely, J. Gergely, S Gerö, R. S. Morgan, C. W. M. Adams, C Orton, Katalin Farkas, A.B. Czuppon and Klára Farkas and has published in prestigious journals such as Nature, The Lancet and Atherosclerosis.

In The Last Decade

S Virág

22 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Virág Hungary	7	101	87	74	59	53	25	312
S Gerö Hungary	9	118 1.2×	194 2.2×	90 1.2×	51 0.9×	83 1.6×	38	420
F F Chao United States	9	186 1.8×	140 1.6×	172 2.3×	40 0.7×	75 1.4×	9	417
Robert F. Ackerman United States	6	114 1.1×	27 0.3×	96 1.3×	24 0.4×	19 0.4×	10	267
Lillemor Mattsson-Hultén Sweden	9	137 1.4×	91 1.0×	121 1.6×	38 0.6×	77 1.5×	12	372
Hans P. Deigner Germany	8	117 1.2×	94 1.1×	134 1.8×	18 0.3×	84 1.6×	10	376
R. S. Lees United States	7	166 1.6×	19 0.2×	96 1.3×	28 0.5×	41 0.8×	10	397
Michael La Belle United States	11	194 1.9×	80 0.9×	163 2.2×	17 0.3×	58 1.1×	16	468
Kouichi Fukunaga Japan	6	85 0.8×	53 0.6×	74 1.0×	12 0.2×	44 0.8×	7	328
Sean J. P. GAVIGAN United Kingdom	8	152 1.5×	25 0.3×	102 1.4×	17 0.3×	28 0.5×	9	381
S.H. Koh Australia	7	49 0.5×	76 0.9×	137 1.9×	16 0.3×	78 1.5×	13	426

Countries citing papers authored by S Virág

Since Specialization

Citations

This map shows the geographic impact of S Virág's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Virág with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Virág more than expected).

Fields of papers citing papers by S Virág

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Virág. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Virág. The network helps show where S Virág may publish in the future.

Co-authorship network of co-authors of S Virág

This figure shows the co-authorship network connecting the top 25 collaborators of S Virág. A scholar is included among the top collaborators of S Virág based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Virág. S Virág is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Virág, S, et al.. (1986). Accumulation of cholesterol ester in cultured smooth muscle cells of congenital hypercholesterolemic (WHHL) rabbits treated with normal and WHHL rabbit plasma LDL.. PubMed. 8(9). 535–42. 7 indexed citations

Virág, S. (1980). Experimental models of atherosclerosis (the insudative theory).. PubMed. 2(3). 111–31. 1 indexed citations

Hermecz, István, et al.. (1979). Nitrogen bridgehead compounds. Part 7: Synthesis of anti-atherosclerotic pyrido[1,2-a]pyrimidines.. PubMed. 29(12). 1833–5. 1 indexed citations

Schneider, Frank, et al.. (1978). Effect of Chinoin-123 on aortic wall permeability of rabbits given forced hyperlipemic diet (distribution of labelled human albumin in thoracic segment of the aorta).. PubMed. 26(4). 178–9. 1 indexed citations

Virág, S, et al.. (1978). Combined vessel injuring action of adjuvant arthritis and cholesterol diet. (III. Action of Chinoin-123 on a new model of experimental atherosclerosis of rat).. PubMed. 26(4). 171–3. 1 indexed citations

Schneider, Frank, et al.. (1978). Effect of Chinoin-123 on the permeability of the aortic wall in rabbits kept on a hyperlipemic diet (Investigation of aortic wall permeability by Evans-blue method).. PubMed. 26(4). 174–7. 1 indexed citations

Virág, S, et al.. (1976). Combined vessel injuring action of adjuvant arthritis and cholesterol feeding. II. The influence of different types of drugs on the new model of experimental atherosclerosis.. PubMed. 24(4). 142–4. 1 indexed citations

Virág, S, et al.. (1972). [Indices of transport of labelled beta-lipoproteins through the wall of the aorta in rabbits with experimental atherosclerosis].. PubMed. 12(8). 61–5. 1 indexed citations

Virág, S, et al.. (1972). Effect of Miscleron (clofibrate) on the labelled lipoprotein uptake of the aorta in normal and cholesterol pretreated rabbits.. PubMed. 20(1). 62–4. 1 indexed citations

10.

Virág, S, et al.. (1970). Uptake of [125I]-β-lipoprotein by aortas and veins of normal and cholesterol-fed rabbits. Atherosclerosis. 11(2). 361–363. 3 indexed citations

11.

Virág, S, et al.. (1968). Uptake of 125I-labeled β-lipoprotein by the aortas of animals differently susceptible to cholesterol-induced atherosclerosis. Journal of Atherosclerosis Research. 8(5). 859–860. 6 indexed citations

12.

Adams, C. W. M., S Virág, R. S. Morgan, & C Orton. (1968). Dissociation of [3H]cholesterol and 125I-labelled plasma protein influx in normal and atheromatous rabbit aorta. Journal of Atherosclerosis Research. 8(4). 679–696. 54 indexed citations

13.

Virág, S, et al.. (1966). [A study of immunological reactions in aged persons].. PubMed. 43(3). 99–103. 1 indexed citations

14.

Jakab, L, et al.. (1966). A PLASMA-SYNALBUMIN ANTAGONIST. The Lancet. 288(7477). 1366–1367. 6 indexed citations

15.

Gerö, S, J. Gergely, Klára Farkas, et al.. (1962). Role of intimal mucoid substances in the pathogenesis of atherosclerosis. Journal of Atherosclerosis Research. 2(4). 276–284. 26 indexed citations

16.

Gergely, J., et al.. (1962). Inhibitory Effect of Some Mucopolysaccharides on the Lipolytic Activity of the Aorta of Animals. Nature. 194(4834). 1181–1182. 3 indexed citations

17.

Gerö, S, et al.. (1961). Role of intimal mucoid substances in the pathogenesis of atherosclerosis. I. Complex formation in vitro between mucopolysaccharides from atherosclerotic aortic intimas and plasma β-lipoprotein and fibrinogen. Journal of Atherosclerosis Research. 1(1). 67–74. 55 indexed citations

18.

Gerö, S, Katalin Farkas, J. Gergely, et al.. (1960). [Inhibition of cholesterol atherosclerosis by immunization with beta-lipoprotein].. PubMed. 101. 1441–7. 2 indexed citations

19.

Gerö, S, Katalin Farkas, J. Gergely, et al.. (1959). [Inhibition of cholesterol arteriosclerosis following immunization by beta-lipoprotein; preliminary report].. PubMed. 100. 1119–20. 1 indexed citations

20.

Gerö, S, J. Gergely, L Jakab, et al.. (1959). INHIBITION OF CHOLESTEROL ATHEROSCLEROSIS BY IMMUNISATION WITH BETA-LIPOPROTEIN. The Lancet. 274(7088). 6–7. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact